Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Magdaleno

Showing results (571-580 of 575) with videos related to

Pageof 58
Sort By:
You have reached the last page of results.This site can display upto 575 results.
Acta Dermato-Venereologica|July 6, 2026
Dupilumab in Difficult-to-treat Chronic Spontaneous Urticaria: A Real-world Multicentre Cohort StudyNidia Planella-Fontanillas, Emilio Berna-Rico, Ignasi Figueras-Nart, et al.
Actas Dermo-Sifiliograficas|March 7, 2024
Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional StudyA Martorell-Calatayud, S Santos-Alarcón, A Sahuquillo-Torralba, et al.
International Journal of Dermatology|September 30, 2025
Immunohistochemical Characterization of JAK Family Expression in the Primary Inflammatory Infiltrate of Lichen Planopilaris and Folliculitis Decalvans, With an Exploratory Clinical Assessment of Oral JAK InhibitorsMiguel Antonio Lasheras-Pérez, María Concepción Garrido-Ruiz, Alejandro Lobato-Berezo, et al.
Actas Dermo-Sifiliograficas|October 25, 2024
Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional StudyA Martorell-Calatayud, S Santos-Alarcón, A Sahuquillo-Torralba, et al.
Salud Publica De Mexico|September 21, 2022
Marisol Arroyo-Hernández, Luis Felipe Alva-López, Adrián Rendón, et al.
Pageof 58

Showing results (571-580 of 575) with videos related to

Sort By:
Pageof 58
You have reached the last page of results.This site can display upto 575 results.
Acta Dermato-Venereologica|July 6, 2026
Dupilumab in Difficult-to-treat Chronic Spontaneous Urticaria: A Real-world Multicentre Cohort StudyNidia Planella-Fontanillas, Emilio Berna-Rico, Ignasi Figueras-Nart, et al.
Actas Dermo-Sifiliograficas|March 7, 2024
Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional StudyA Martorell-Calatayud, S Santos-Alarcón, A Sahuquillo-Torralba, et al.
International Journal of Dermatology|September 30, 2025
Immunohistochemical Characterization of JAK Family Expression in the Primary Inflammatory Infiltrate of Lichen Planopilaris and Folliculitis Decalvans, With an Exploratory Clinical Assessment of Oral JAK InhibitorsMiguel Antonio Lasheras-Pérez, María Concepción Garrido-Ruiz, Alejandro Lobato-Berezo, et al.
Actas Dermo-Sifiliograficas|October 25, 2024
Real-world Safety and Efficacy of Risankizumab in Psoriatic Patients: A Multicenter, Retrospective, and Not-interventional StudyA Martorell-Calatayud, S Santos-Alarcón, A Sahuquillo-Torralba, et al.
Salud Publica De Mexico|September 21, 2022
Marisol Arroyo-Hernández, Luis Felipe Alva-López, Adrián Rendón, et al.
Pageof 58